- Home
- SXTP vs CPHI Comparison
SXTP vs CPHI Comparison
Compare SXTP & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTP
- CPHI
- Stock Information
- Founded
- SXTP 2010
- CPHI N/A
- Country
- SXTP United States
- CPHI China
- Employees
- SXTP N/A
- CPHI N/A
- Industry
- SXTP Biotechnology: Pharmaceutical Preparations
- CPHI Biotechnology: Pharmaceutical Preparations
- Sector
- SXTP Health Care
- CPHI Health Care
- Exchange
- SXTP Nasdaq
- CPHI Nasdaq
- Market Cap
- SXTP 5.9M
- CPHI 4.7M
- IPO Year
- SXTP 2023
- CPHI N/A
- Fundamental
- Price
- SXTP $1.44
- CPHI $1.98
- Analyst Decision
- SXTP Buy
- CPHI
- Analyst Count
- SXTP 2
- CPHI 0
- Target Price
- SXTP $3.00
- CPHI N/A
- AVG Volume (30 Days)
- SXTP 69.3K
- CPHI 57.3K
- Earning Date
- SXTP 11-13-2025
- CPHI 11-12-2025
- Dividend Yield
- SXTP N/A
- CPHI N/A
- EPS Growth
- SXTP N/A
- CPHI N/A
- EPS
- SXTP N/A
- CPHI N/A
- Revenue
- SXTP $984,494.00
- CPHI $4,396,201.00
- Revenue This Year
- SXTP $81.41
- CPHI N/A
- Revenue Next Year
- SXTP $95.63
- CPHI N/A
- P/E Ratio
- SXTP N/A
- CPHI N/A
- Revenue Growth
- SXTP 128.70
- CPHI N/A
- 52 Week Low
- SXTP $1.22
- CPHI $1.20
- 52 Week High
- SXTP $12.45
- CPHI $3.35
- Technical
- Relative Strength Index (RSI)
- SXTP 52.52
- CPHI 72.02
- Support Level
- SXTP $1.36
- CPHI $1.77
- Resistance Level
- SXTP $1.45
- CPHI $2.03
- Average True Range (ATR)
- SXTP 0.08
- CPHI 0.13
- MACD
- SXTP 0.02
- CPHI 0.05
- Stochastic Oscillator
- SXTP 73.77
- CPHI 92.75
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.